FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dexrazoxane Injection
Status: Resolved
»Duration of Shortage: 07/05/2017 - 02/26/2020
»Therapeutic Categories: Oncology; Pediatric

Expand all

Clinigen Healthcare Ltd (Revised 02/26/2020)

Company Contact Information:
615-255-0068

Presentation
  • Totect® (Dexrazoxane) for injection; 1 vial (500 mg)(NDC 66220-110-01); distributed by Cumberland Pharmaceuticals
Note:
  • Available

Gland Pharma (Revised 02/26/2020)

Company Contact Information:
609-250-7990

Presentation
  • 500 mg per vial (NDC 72266-101-01); distributed by Fosun Pharma USA Inc.
  • 500 mg per vial (NDC 51991-942-98); distributed by Breckenridge Pharmaceutical, Inc.
  • 500 mg per vial (NDC 47781-578-07); distributed by Alvogen, Inc.
Note:
  • Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 02/26/2020)

Company Contact Information:
800-631-2174

Presentation
  • 250 mg per vial (NDC 0143-9247-01); distributed by West-Ward
  • 500 mg per vial (NDC 0143-9248-01); distributed by West-Ward
Note:
  • Available

Mylan Institutional (Revised 02/26/2020)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation
  • 250 mg Kit (NDC 67457-207-25)
  • 500 mg Kit (NDC 67457-208-50)
Note:
  • Available

Pfizer Pharmaceuticals (Revised 02/26/2020)

Company Contact Information:
844-646-4398

Presentation
  • Zinecard 250 mg; Single Dose Vial (NDC 0013-8717-62)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English